NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
05/14/2024
Back to search
Official data from USPTO
LIPAC ONCOLOGY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LIPAC ONCOLOGY
ST13
US500000087614567Class
42
Filing
87614567
Registration
5501155
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
05/14/2024
Trademark type
Word
Nice classes
42
Filing date
09/19/2017
Registration date
06/26/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/14/2024
Last transaction
05/14/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
11/01/2016
First use in commerce
11/01/2016
Drawing code
4
Owner type
03
Owner location
Menlo Park, CA
Examiner
BULLOFF, TOBY ELLEN
Law office
N10
Current location
TMO LAW OFFICE 119
Holders and representatives
Holders
LIPAC ONCOLOGY, INC.
Lipac Oncology LLC
Lipac Oncology LLC
Representatives
Kristin S. Cornuelle ORRICK, HERRINGTON & SUTCLIFFE LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pharmaceutical drug development services; pharmaceutical products development; pharmaceutical research and development; pharmaceutical research services
Publications
History of USPTO decisions and trademark events.
26 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/14/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/14/2024
E815
TEAS SECTION 8 & 15 RECEIVED
11/09/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/26/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/23/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/01/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/01/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/01/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/01/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/01/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
06/26/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/10/2018
PUBO
PUBLISHED FOR OPPOSITION
04/10/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/21/2018
ALIE
ASSIGNED TO LIE
03/08/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/02/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/01/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/28/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/28/2018
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
01/03/2018
GPRA
PRIORITY ACTION E-MAILED
01/03/2018
CPRA
PRIORITY ACTION WRITTEN
01/03/2018
DOCK
ASSIGNED TO EXAMINER
12/22/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/25/2017
NWAP
NEW APPLICATION ENTERED
09/22/2017
Continuous trademark protection
Get notified about every new filing that threatens LIPAC ONCOLOGY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.